Drugs Made In America Acquisition II

DMIINasdaq United States Finance Blank Checks

Market cap

$646.874 M

$10.16 -0.15%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

$4.19M

#2212 by earnings

Shares outstanding

63,700,000

Latest filing cover page

P/E ratio

154.5

Cap ÷ net income

Other share classes

Drugs Made In America Acquisition II lists more than one class of stock. Company figures above cover all classes combined.

DMIIR DMIIU

Blank Checks, ranked by market cap

All 42 →

#1Drugs Made In America Acquisition IIDMII$646.9M
#2Idea AcquisitionIACO$437.1M
#3Prenetics GlobalPRE$412.3M
#4Berto Acquisition Corp. IIGUAC$390.3M
#5Berto AcquisitionTACO$380.8M

What if Drugs Made In America Acquisition II were worth as much as…

Open the what-if tool →

Gold $30.3T

$475,259.88

Per share 46,801× higher

Bitcoin $1.72T

$26,998.49

Per share 2,659× higher

Nvidia $5.48T

$86,026.03

Per share 8,471× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Drugs Made In America Acquisition II are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.